Keywords: Mental illnesses, Drugs in Development, R&D, PhRMA, USA

US drugmakers have almost 200 medicines in development for mental illnesses

Article | 15 July 2012

Research-based biopharmaceutical companies in the USA are developing 187 innovative medicines to help the nearly 60 million patients in the country who ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in